NASDAQ:UXIN

Uxin Competitors

$1.22
-0.01 (-0.41 %)
(As of 04/20/2021 12:03 PM ET)
Add
Compare
Today's Range
$1.21
Now: $1.22
$1.24
50-Day Range
$1.02
MA: $1.25
$1.97
52-Week Range
$0.72
Now: $1.22
$2.02
Volume78,585 shs
Average Volume11.04 million shs
Market Capitalization$359.51 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.28

Competitors

Uxin (NASDAQ:UXIN) Vs. RDWR, TRHC, IIIV, GSKY, QNST, and IDEX

Should you be buying UXIN stock or one of its competitors? Companies in the industry of "business services, not elsewhere classified" are considered alternatives and competitors to Uxin, including Radware (RDWR), Tabula Rasa HealthCare (TRHC), i3 Verticals (IIIV), GreenSky (GSKY), QuinStreet (QNST), and Ideanomics (IDEX).

Uxin (NASDAQ:UXIN) and Radware (NASDAQ:RDWR) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Insider and Institutional Ownership

70.5% of Radware shares are held by institutional investors. 21.6% of Radware shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Uxin and Radware's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Uxin-499.36%N/A-105.30%
Radware5.70%4.87%3.12%

Analyst Ratings

This is a breakdown of recent recommendations for Uxin and Radware, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Uxin0000N/A
Radware03202.40

Radware has a consensus target price of $30.00, indicating a potential upside of 4.02%. Given Radware's higher probable upside, analysts plainly believe Radware is more favorable than Uxin.

Risk & Volatility

Uxin has a beta of -0.28, suggesting that its share price is 128% less volatile than the S&P 500. Comparatively, Radware has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.

Earnings & Valuation

This table compares Uxin and Radware's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Uxin$227.64 million1.58$-350,840,000.00($0.60)-2.03
Radware$252.07 million5.37$22.57 million$0.5750.60

Radware has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than Radware, indicating that it is currently the more affordable of the two stocks.

Summary

Radware beats Uxin on 13 of the 13 factors compared between the two stocks.

Uxin (NASDAQ:UXIN) and Tabula Rasa HealthCare (NASDAQ:TRHC) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Profitability

This table compares Uxin and Tabula Rasa HealthCare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Uxin-499.36%N/A-105.30%
Tabula Rasa HealthCare-19.48%-11.53%-4.22%

Analyst Ratings

This is a breakdown of recent recommendations for Uxin and Tabula Rasa HealthCare, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Uxin0000N/A
Tabula Rasa HealthCare06302.33

Tabula Rasa HealthCare has a consensus target price of $52.20, indicating a potential upside of 19.37%. Given Tabula Rasa HealthCare's higher probable upside, analysts plainly believe Tabula Rasa HealthCare is more favorable than Uxin.

Risk and Volatility

Uxin has a beta of -0.28, meaning that its stock price is 128% less volatile than the S&P 500. Comparatively, Tabula Rasa HealthCare has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500.

Earnings & Valuation

This table compares Uxin and Tabula Rasa HealthCare's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Uxin$227.64 million1.58$-350,840,000.00($0.60)-2.03
Tabula Rasa HealthCare$284.71 million3.79$-32,440,000.00($0.25)-174.92

Tabula Rasa HealthCare has higher revenue and earnings than Uxin. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than Uxin, indicating that it is currently the more affordable of the two stocks.

Summary

Tabula Rasa HealthCare beats Uxin on 9 of the 11 factors compared between the two stocks.

Uxin (NASDAQ:UXIN) and i3 Verticals (NASDAQ:IIIV) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations for Uxin and i3 Verticals, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Uxin0000N/A
i3 Verticals10612.88

i3 Verticals has a consensus target price of $37.25, indicating a potential upside of 12.00%. Given i3 Verticals' higher probable upside, analysts plainly believe i3 Verticals is more favorable than Uxin.

Earnings & Valuation

This table compares Uxin and i3 Verticals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Uxin$227.64 million1.58$-350,840,000.00($0.60)-2.03
i3 Verticals$150.13 million7.02$-420,000.00$0.5164.31

i3 Verticals has lower revenue, but higher earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than i3 Verticals, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Uxin and i3 Verticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Uxin-499.36%N/A-105.30%
i3 Verticals-0.28%10.30%5.09%

Insider and Institutional Ownership

61.1% of i3 Verticals shares are held by institutional investors. 40.1% of i3 Verticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

Uxin has a beta of -0.28, suggesting that its share price is 128% less volatile than the S&P 500. Comparatively, i3 Verticals has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500.

Summary

i3 Verticals beats Uxin on 12 of the 14 factors compared between the two stocks.

GreenSky (NASDAQ:GSKY) and Uxin (NASDAQ:UXIN) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

Analyst Recommendations

This is a breakdown of recent ratings for GreenSky and Uxin, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
GreenSky44001.50
Uxin0000N/A

GreenSky currently has a consensus target price of $4.0938, suggesting a potential downside of 24.61%. Given GreenSky's higher probable upside, equities analysts clearly believe GreenSky is more favorable than Uxin.

Earnings and Valuation

This table compares GreenSky and Uxin's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GreenSky$529.65 million1.88$31.98 million$0.579.54
Uxin$227.64 million1.58$-350,840,000.00($0.60)-2.03

GreenSky has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than GreenSky, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares GreenSky and Uxin's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GreenSky0.72%-15.29%2.19%
Uxin-499.36%N/A-105.30%

Insider & Institutional Ownership

35.5% of GreenSky shares are owned by institutional investors. 54.8% of GreenSky shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

GreenSky has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500. Comparatively, Uxin has a beta of -0.28, suggesting that its stock price is 128% less volatile than the S&P 500.

Summary

GreenSky beats Uxin on 11 of the 12 factors compared between the two stocks.

QuinStreet (NASDAQ:QNST) and Uxin (NASDAQ:UXIN) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

Profitability

This table compares QuinStreet and Uxin's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
QuinStreet6.29%12.51%8.58%
Uxin-499.36%N/A-105.30%

Earnings and Valuation

This table compares QuinStreet and Uxin's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QuinStreet$490.34 million2.10$18.10 million$0.3456.88
Uxin$227.64 million1.58$-350,840,000.00($0.60)-2.03

QuinStreet has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than QuinStreet, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

86.6% of QuinStreet shares are owned by institutional investors. 9.0% of QuinStreet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

QuinStreet has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Comparatively, Uxin has a beta of -0.28, suggesting that its stock price is 128% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings for QuinStreet and Uxin, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
QuinStreet00203.00
Uxin0000N/A

QuinStreet currently has a consensus target price of $26.00, suggesting a potential upside of 32.52%. Given QuinStreet's higher probable upside, equities analysts clearly believe QuinStreet is more favorable than Uxin.

Summary

QuinStreet beats Uxin on 13 of the 13 factors compared between the two stocks.

Ideanomics (NASDAQ:IDEX) and Uxin (NASDAQ:UXIN) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Profitability

This table compares Ideanomics and Uxin's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ideanomics-998.07%-212.69%-116.68%
Uxin-499.36%N/A-105.30%

Earnings & Valuation

This table compares Ideanomics and Uxin's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ideanomics$44.57 million21.92$-97,680,000.00N/AN/A
Uxin$227.64 million1.58$-350,840,000.00($0.60)-2.03

Ideanomics has higher earnings, but lower revenue than Uxin.

Insider & Institutional Ownership

4.7% of Ideanomics shares are owned by institutional investors. 21.5% of Ideanomics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations and price targets for Ideanomics and Uxin, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ideanomics00103.00
Uxin0000N/A

Ideanomics presently has a consensus price target of $7.00, suggesting a potential upside of 197.87%. Given Ideanomics' higher probable upside, research analysts clearly believe Ideanomics is more favorable than Uxin.

Summary

Ideanomics beats Uxin on 6 of the 11 factors compared between the two stocks.


Uxin Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Radware logo
RDWR
Radware
1.5$28.84-0.6%$1.36 billion$252.07 million99.45
Tabula Rasa HealthCare logo
TRHC
Tabula Rasa HealthCare
1.3$43.73-1.1%$1.07 billion$284.71 million-16.44Analyst Downgrade
i3 Verticals logo
IIIV
i3 Verticals
1.7$32.80-1.2%$1.07 billion$150.13 million-820.00
GreenSky logo
GSKY
GreenSky
1.3$5.44-7.0%$1.06 billion$529.65 million108.82
QuinStreet logo
QNST
QuinStreet
2.0$19.34-3.1%$1.06 billion$490.34 million32.78
Ideanomics logo
IDEX
Ideanomics
1.3$2.33-0.9%$985.39 million$44.57 million-1.97Analyst Report
OptimizeRx logo
OPRX
OptimizeRx
1.5$47.54-5.8%$845.56 million$24.60 million-125.11Analyst Report
Gravity logo
GRVY
Gravity
0.7$116.49-2.6%$830.34 million$307.18 million20.08
Viad logo
VVI
Viad
1.1$39.63-2.3%$830.18 million$1.37 billion-4.17
Advantage Solutions logo
ADV
Advantage Solutions
1.7$12.72-1.2%$727.16 millionN/A0.00
Qiwi logo
QIWI
Qiwi
1.9$10.38-4.4%$679.81 million$635.40 million6.78Dividend Announcement
Gap Up
Cass Information Systems logo
CASS
Cass Information Systems
0.9$45.75-0.7%$663.41 million$157.24 million26.60Upcoming Earnings
Decrease in Short Interest
Rimini Street logo
RMNI
Rimini Street
1.7$7.94-2.3%$624.51 million$281.05 million-30.54
Liquidity Services logo
LQDT
Liquidity Services
1.3$16.66-5.5%$613.60 million$205.94 million-151.45Increase in Short Interest
Newtek Business Services logo
NEWT
Newtek Business Services
1.4$27.15-2.4%$593.82 million$59.29 million18.22Analyst Upgrade
Decrease in Short Interest
International Money Express logo
IMXI
International Money Express
2.0$14.47-1.5%$561.04 million$319.60 million18.55News Coverage
MoneyGram International logo
MGI
MoneyGram International
1.4$6.51-7.1%$540.72 million$1.29 billion-17.13
Priority Technology logo
PRTH
Priority Technology
1.7$6.76-1.9%$466.03 million$371.85 million24.14Gap Up
Resources Connection logo
RGP
Resources Connection
1.7$13.91-2.0%$465.76 million$703.35 million36.61Analyst Upgrade
Limelight Networks logo
LLNW
Limelight Networks
1.8$3.50-1.4%$440.68 million$200.63 million-58.33Decrease in Short Interest
Emerald logo
EEX
Emerald
0.7$5.01-3.4%$374.38 million$360.90 million-0.55Increase in Short Interest
Gap Up
Digital Media Solutions logo
DMS
Digital Media Solutions
1.5$10.66-4.0%$359.24 millionN/A0.00
Waitr logo
WTRH
Waitr
1.6$2.48-3.6%$286.62 million$191.68 million-0.80
The9 logo
NCTY
The9
0.5$19.36-4.6%$278.93 million$50,000.000.00
QH
Quhuo
0.7$4.79-1.5%$252.26 million$295.30 million0.00
comScore logo
SCOR
comScore
2.0$3.17-2.5%$246.31 million$388.64 million-3.91
Points International logo
PCOM
Points International
1.1$15.10-0.3%$225.22 million$401.18 million-94.37News Coverage
Gap Up
PaySign logo
PAYS
PaySign
1.1$3.85-2.9%$199.77 million$34.67 million-64.17
DHI Group logo
DHX
DHI Group
2.0$3.14-1.0%$165.91 million$149.37 million-5.32
MOGU logo
MOGU
MOGU
1.8$1.56-3.8%$156.07 million$117.97 million-0.60
PFSweb logo
PFSW
PFSweb
1.4$6.99-3.6%$147.58 million$294.02 million-58.25
ServiceSource International logo
SREV
ServiceSource International
1.8$1.44-4.2%$134.28 million$216.13 million-6.86
Steel Connect logo
STCN
Steel Connect
0.6$1.96-1.0%$124.74 million$782.81 million-7.54
Marchex logo
MCHX
Marchex
1.8$2.81-0.4%$115.66 million$106.13 million-3.96
China Customer Relations Centers logo
CCRC
China Customer Relations Centers
0.5$6.14-1.1%$113.83 million$173.41 million0.00
HGBL
Heritage Global
2.0$3.18-1.6%$112.43 million$26.17 million24.46Gap Down
36Kr logo
KRKR
36Kr
1.3$2.95-6.1%$110.61 million$94.17 million-5.27
Exela Technologies logo
XELA
Exela Technologies
0.8$1.73-4.6%$106.73 million$1.56 billion-0.51Increase in Short Interest
News Coverage
MKD
Molecular Data
0.0$0.80-1.9%$93.87 million$1.90 billion0.00Gap Down
TC
TuanChe
0.3$4.07-2.0%$81.85 million$92.62 million-3.18Analyst Report
Decrease in Short Interest
RSSS
Research Solutions
0.0$2.30-3.0%$60.44 million$31.06 million-76.67
ALJJ
ALJ Regional
0.6$1.28-3.1%$55.86 million$389.15 million-0.80Gap Up
SPAR Group logo
SGRP
SPAR Group
0.7$1.61-3.1%$34.22 million$252.88 million53.67
BSQUARE logo
BSQR
BSQUARE
0.5$2.32-6.5%$32.85 million$59.28 million-10.09Increase in Short Interest
SilverSun Technologies logo
SSNT
SilverSun Technologies
0.6$6.06-6.1%$32.54 million$38.50 million0.00
The OLB Group logo
OLB
The OLB Group
1.4$4.46-2.0%$32.39 million$10.29 million0.00Decrease in Short Interest
Cypress Environmental Partners logo
CELP
Cypress Environmental Partners
1.3$2.05-5.9%$25.28 million$401.65 million-29.28News Coverage
CREG
China Recycling Energy
0.5$7.00-7.0%$23.41 million$870,000.000.00Decrease in Short Interest
News Coverage
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.